Pearl Gray

3.2k citations
14 papers · 2.4k indexed · 1 hit paper · h-index 13

Pearl Gray

14 papers receiving 2.4k citations

Hit Papers

Mal (MyD88-adapter-like) is required for Toll-like recept...1.0k20012026200920172505007501000

Peers

Pearl Gray
Comparison fields: 5 of 95
  • Immunology 1.9k
  • Cancer Research 474
  • Virology 132
  • Microbiology 166
  • Oncology 356
Replace Kenji Funami with:
Kenji Funami Japan
Elizabeth E. M. Bates France
Gareth Brady Ireland
Sean E. Doyle United States
Jason Goode United States
Masanaka Sugiyama Japan
Suzanne Mudd United States
J Y Djeu United States
Sosathya Sovath United States
Marc S. Lamphier United States
Pearl Gray relative to Kenji Funami Japan Kenji Funami's profile →
Citations per field
00.5×1.5×1.9×
Kenji Funami · 1×
Citations per year

Countries citing papers authored by Pearl Gray

Since Specialization
Citations

This map shows the geographic impact of Pearl Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearl Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearl Gray more than expected).

Fields of papers citing papers by Pearl Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearl Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearl Gray. The network helps show where Pearl Gray may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pearl Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pearl Gray Line = papers co-authored together Pearl Gray links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201128
2 201033
3 201060
4 20091
5 200915
6 200924
7 2006434
8 200323
9 2003307
10 200364
11
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transductionbreakdown →
20011006
12 198543
13 1985142
14 1985263

About Pearl Gray

Pearl Gray is a scholar working on Immunology, Microbiology and Cancer Research, having authored 14 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune Response and Inflammation (9 papers), NF-κB Signaling Pathways (7 papers), Immune cells in cancer (2 papers), Antimicrobial Peptides and Activities (2 papers), Urinary Tract Infections Management (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Virus-based gene therapy research (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Immunology (1.9k citations), Cancer Research (474 citations) and Virology (132 citations). Pearl Gray has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Luke O'neill, Ashley Mansell, Mary T. Harte, Andrew Bowie, Aisling Dunne, Caroline A. Jefferies, Katherine A. Fitzgerald, Elizabeth Brint, Timothy A. Bird and Gareth Brady. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Infection and Immunity, Nature Immunology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026